Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Verifi1 & Life2 Launch New Managed Service for Employer Health Plans


Initiative Utilizes AI, Machine Learning & Predictive Models

SOUTHFIELD, Mich and ALPHARETTA, Ga., May 8, 2024 /PRNewswire-PRWeb/ -- Verifi1, Inc., a provider of innovative risk mitigation and verification solutions and Life2, Inc., an innovator in healthcare outcome analytics and risk mitigation, announced today their employer health plan collaborative managed service. The combined initiative provides Verifi1 a license to utilize Life2 artificial intelligence (AI), machine learning and predictive modeling technologies to bring new products and services to market.

"Our partnership with Life2 allows us to rapidly leverage and integrate new, emerging technologies into our platform. These include innovative services such as real-time claims analysis/audits and predictive utilization, plan design and stop/loss services."

Terry Niles, President of Verifi1, said: "Our clients and partners value our range of eligibility applications and risk mitigation services, including Dependent Verification and Life Event Services. Our partnership with Life2 allows us to rapidly leverage and integrate new, emerging technologies into our platform. These include innovative services such as real-time claims analysis/audits and predictive utilization, plan design and stop/loss services. These provide client benefits such as reducing wasteful and fraudulent claims expenses, optimizing health plan design, and proactively mitigating future hospitalizations and medical, pharmaceutical, and other health claim events."

The first offering - a comprehensive Claims Analysis Service - officially launched on May 1st. This service provides both a Retrospective Claims Review as well as a Real-Time Claims Analysis. The retrospective review performs automated historical claims audits of any volume and any type of claim such as medical, pharmaceutical, dental and vision. This analysis provides comprehensive reports on an administrator's past claims adjudication performance, billing leakage via waste, fraud, abuse and administrative errors, and plan remediation. The Real-Time Claims Analysis flags suspect claims and determines proper claim amounts prior to payment. This reduces ongoing billing leakage of all types and unnecessary administrative work by catching problems before claims are paid.

The fully integrated managed services offering generates new insights, risk predictions, and variance analysis that optimize outcomes and lower costs. The Companies project a conservative annual savings of 3% to 10% of annual healthcare spend for its clients. The service can be used by all members of the health plan services market, including benefits advisors, brokers, third party administrators, care management firms, and stop/loss carriers.

Richard Egan, President, and CEO of Life2 said: "Verifi1's commitment to deliver value and improve financial outcomes for its partners and clients is an exciting match for our company and platform. Our technology and business model were specifically designed to deliver immediate value to partners that want to rapidly commercialize new offerings to their markets. Our licensing model, deep technical expertise and platform makes us a perfect partner to quickly deploy complex technologies such as AI and machine learning into existing products and services. Our team looks forward to helping Verifi1 grow revenue and market share."

Media Contact

Rick Egan, Life2, Inc., 1 (404) 805-1812, [email protected], www.life2inc.com

SOURCE Life2, Inc.


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: